Corvus Pharmaceuticals Insider Trades

-0.07 (-2.52 %)
(As of 04/16/2021 04:00 PM ET)
Today's Range
Now: $2.71
50-Day Range
MA: $3.09
52-Week Range
Now: $2.71
Volume239,491 shs
Average Volume845,024 shs
Market Capitalization$103.82 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Buying and Selling Activity

Insider Ownership Percentage: 45.12%
Insider Buying (Last 12 Months): $4,849,999.00
Insider Selling (Last 12 Months): $8,167,109.22

Insider Buying and Selling by Quarter

Corvus Pharmaceuticals (NASDAQ CRVS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/17/2021Orbimed Advisors LlcDirectorBuy1,285,714$3.50$4,499,999.00  
2/17/2021Richard A Md MillerCEOBuy100,000$3.50$350,000.00
7/8/2020Holdings A/S NovoMajor ShareholderSell1,538,062$5.31$8,167,109.222,130,938  
11/12/2019Richard A Md MillerCEOBuy272$2.90$788.80  
8/7/2019Richard A Md MillerInsiderBuy7,500$3.56$26,700.00  
8/6/2019Orbimed Advisors LlcDirectorBuy142,656$3.51$500,722.56  
7/25/2019Holdings A/S NovoMajor ShareholderSell1,400,000$4.00$5,600,000.004,380,800  
7/23/2019Holdings A/S NovoMajor ShareholderSell39,716$5.32$211,289.124,380,800  
7/1/2019Orbimed Advisors LlcDirectorBuy657,344$3.72$2,445,319.68  
6/27/2019Peter A ThompsonDirectorBuy32,923$3.34$109,962.82  
6/13/2019Richard A Md MillerCEOBuy343$3.52$1,207.36  
6/11/2019Richard A Md MillerInsiderBuy15,212$3.49$53,089.88  
6/7/2019Richard A Md MillerCEOBuy9,212$3.37$31,044.44  
6/6/2019Leiv LeaCFOBuy15,500$3.56$55,180.00  
12/27/2018Richard A Md MillerInsiderBuy20,000$3.29$65,800.00  
12/27/2018Richard A Md MillerCEOBuy20,000$3.29$65,800.00  
12/21/2018Leiv LeaCFOBuy24,700$4.15$102,505.00  
12/20/2018Richard A Md MillerCEOBuy10,000$4.40$44,000.00  
12/6/2018Richard A Md MillerCEOBuy5,000$5.99$29,950.00  
12/4/2018Richard A Md MillerCEOBuy1,502$5.95$8,936.90  
3/12/2018Adams Street Partners LlcMajor ShareholderBuy588,235$8.50$4,999,997.504,420,516  
3/12/2018Richard A Md MillerCEOBuy100,000$8.50$850,000.00  
11/20/2017Richard A Md MillerCEOBuy10,000$10.79$107,900.00  
6/23/2017Holdings A/S NovoMajor ShareholderBuy20,000$10.95$219,000.003,244,046  
6/13/2017Richard A Md MillerInsiderBuy25,000$9.88$247,000.00  
6/24/2016Orbimed Advisors LlcDirectorBuy1,000$12.98$12,980.00  
6/21/2016Orbimed Advisors LlcDirectorBuy38,383$12.75$489,383.25  
6/16/2016Orbimed Advisors LlcDirectorBuy20,000$12.35$247,000.00  
6/10/2016Peter A ThompsonDirectorBuy50,000$12.96$648,000.00  
5/20/2016Orbimed Advisors LlcDirectorBuy4,716$13.09$61,732.44  
5/19/2016Peter A ThompsonDirectorBuy6,800$11.77$80,036.00  
5/13/2016Richard A Md MillerCEOBuy30,300$10.00$303,000.00  
5/12/2016A/S NovoMajor ShareholderBuy70,000$10.00$700,000.003,224,046  
3/29/2016Adams Street Partners LlcMajor ShareholderBuy200,000$15.00$3,000,000.00  
3/29/2016Peter A ThompsonDirectorBuy550,000$15.00$8,250,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 4/18/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.